TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20512336

Group type: EXPERIMENTAL
Intervention: Strontium ranelate 2 g/day
Number of subjects: 88

Group type: COMPARATOR
Intervention: Alendronate 70 mg/week
Number of subjects: 88
Study: 17085009

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Uninterrupted rest
Number of subjects: 30
Study: 15692829

Group type: EXPERIMENTAL
Intervention: Theophylline (6 mg kg (‐1) body weight) intravenously
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Verapamil (5 mg) intravenously
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1,3-Dimethyluric acid
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Norverapamil
Number of subjects: 20
Study: 11994030

Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 10008
Study: 10215747

Group type: EXPERIMENTAL
Intervention: Selegiline (5 mg, 10 mg, 20 mg, 40 mg) with oral contraceptives
Number of subjects: 8

Group type: COMPARATOR
Intervention: Selegiline (5 mg, 10 mg, 20 mg, 40 mg) without oral contraceptives
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Selegiline (5 mg, 10 mg, 20 mg, 40 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Desmethylselegiline
Number of subjects: 8
Study: 8584010

Group type: EXPERIMENTAL
Intervention: Mid-term placenta from GDM patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Full-term placenta from GDM patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mid-term placenta from normal pregnant women (N)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placental membrane protein content in GDM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Competitive binding assay in GDM patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Competitive binding assay in normal pregnant women (N)
Number of subjects: 0
Study: 2601986

Group type: EXPERIMENTAL
Intervention: Oxybutynin chloride and verapamil combination
Number of subjects: 14

Group type: COMPARATOR
Intervention: Verapamil alone
Number of subjects: 14

Group type: COMPARATOR
Intervention: Oxybutynin chloride alone
Number of subjects: 14
Study: 778564

Group type: EXPERIMENTAL
Intervention: Gaviscon (alginate/alginic acid plus antacid)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard antacid
Number of subjects: 20
Study: 30404676

Group type: EXPERIMENTAL
Intervention: Square‐stepping Exercise (SSE) 2x/week for 24 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 28489641

Group type: EXPERIMENTAL
Intervention: Sevoflurane General Anesthesia (GA)
Number of subjects: 722

Group type: COMPARATOR
Intervention: Bupivacaine Regional Anesthesia (RA)
Number of subjects: 722
Study: 26603973

Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 0
Study: 23152490

Group type: EXPERIMENTAL
Intervention: Reduced model with 12 factors (concordance probability estimate, 0.693)
Number of subjects: 6975

Group type: EXPERIMENTAL
Intervention: Full final model with 25 predictors (concordance probability estimate, 0.70)
Number of subjects: 6975

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of biomarkers (high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide)
Number of subjects: 6975
Study: 21610356

Group type: EXPERIMENTAL
Intervention: Low mean arterial pressure (LMAP) strategy with target MAP of 50 mm Hg
Number of subjects: 90

Group type: COMPARATOR
Intervention: High mean arterial pressure (HMAP) strategy with standard fluid resuscitation to a target MAP of 65 mm Hg
Number of subjects: 90
Study: 19390963

Group type: EXPERIMENTAL
Intervention: 6-week psycho-educational group intervention
Number of subjects: 411

Group type: COMPARATOR
Intervention: Control condition (print material only)
Number of subjects: 411
Study: 17145854

Group type: EXPERIMENTAL
Intervention: HPV16 L2E7E6 vaccine (533-mug) administered thrice at monthly intervals to healthy volunteers
Number of subjects: 69
Study: 12843005

Group type: EXPERIMENTAL
Intervention: Binax NOW S. pneumoniae urinary antigen test
Number of subjects: 107
Study: 11310378

Group type: EXPERIMENTAL
Intervention: L-carnitine (2 g/day for 3 months)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 8878600

Group type: EXPERIMENTAL
Intervention: Oral ofloxacin (7.5 mg.kg of body weight‐1 given over 30 min)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Intravenous ofloxacin (7.5 mg.kg of body weight‐1)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Oral ofloxacin
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Intravenous and oral ofloxacin
Number of subjects: 17
Study: 1725032

Group type: EXPERIMENTAL
Intervention: Ramipril monotherapy (1.25-10 mg/day)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Ramipril (5 mg/day) plus piretanide (3 mg/day)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Captopril (100 mg/day)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Enalapril (10-20 mg/day)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (50 mg/day)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/day)
Number of subjects: 105
Study: 6338905

Group type: EXPERIMENTAL
Intervention: Timolol 0.25%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 0
Study: 29945801

Group type: EXPERIMENTAL
Intervention: DMEK
Number of subjects: 38

Group type: COMPARATOR
Intervention: UT‐DSAEK
Number of subjects: 38
Study: 31097284

Group type: EXPERIMENTAL
Intervention: Intra-oral (IO) bone graft harvesting
Number of subjects: 23

Group type: COMPARATOR
Intervention: Extra-oral (EO) bone graft harvesting
Number of subjects: 23
Study: 26813209

Group type: EXPERIMENTAL
Intervention: Daily 4000 IU vitamin D plus a prenatal vitamin containing 400 IU vitamin D
Number of subjects: 876

Group type: COMPARATOR
Intervention: Placebo plus a prenatal vitamin containing 400 IU vitamin D
Number of subjects: 876
Study: 24297848

Group type: EXPERIMENTAL
Intervention: Exercise intervention in sedentary, overweight/obese individuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T2D-derived myotubes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glucose and palmitate in vitro
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Circulating irisin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fndc5 in adipose tissue and irisin in plasma
Number of subjects: 0
Study: 22337680

Group type: EXPERIMENTAL
Intervention: Amoxicillin (1500 mg/d for 10 days)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo (10 days)
Number of subjects: 166
Study: 20664229

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Taste-matched placebo
Number of subjects: 0
Study: 17906193

Group type: EXPERIMENTAL
Intervention: EGCG (Teavigo) 150 mg capsule twice daily
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 38
Study: 15723896

Group type: EXPERIMENTAL
Intervention: Disclosure group (n = 19)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 34
Study: 12184147

Group type: EXPERIMENTAL
Intervention: Olein Group (OG) - 100% olein
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mix Group (MG) - 50% olein
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group (CG) - regular fats
Number of subjects: 60
Study: 9542187

Group type: EXPERIMENTAL
Intervention: ITT
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sidefocus Technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Incision
Number of subjects: 80

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 80

Group type: COMPARATOR
Intervention: TURP and Incision
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Laser Techniques (ITT and Sidefocus)
Number of subjects: 80
Study: 7845546

Group type: COMPARATOR
Intervention: Atenolol (100 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Atenolol plus melatonin (1 mg at 19.30 h and 0.75 mg at 21.00 and 23.00 h)
Number of subjects: 16
Study: 3385910

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (160 or 320 mg daily)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Intravenous methylprednisolone (500 or 1000 mg daily)
Number of subjects: 77
Study: 31731093

Group type: EXPERIMENTAL
Intervention: Training program for partial automation system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untrained drivers
Number of subjects: 0
Study: 30520317

Group type: EXPERIMENTAL
Intervention: Uncemented HA-coated femoral stem
Number of subjects: 26

Group type: COMPARATOR
Intervention: Cemented femoral stem
Number of subjects: 26
Study: 28701493

Group type: EXPERIMENTAL
Intervention: Creatine (40 g daily for up to 48 months)
Number of subjects: 553

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Creatine
Number of subjects: 553
Study: 26372412

Group type: EXPERIMENTAL
Intervention: Buprenorphine (20 μg/h) transdermal patch
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo transdermal patch
Number of subjects: 22
Study: 23141049

Group type: EXPERIMENTAL
Intervention: 1/3D-1 yr
Number of subjects: 1355

Group type: EXPERIMENTAL
Intervention: FD-3 yr
Number of subjects: 1355

Group type: COMPARATOR
Intervention: FD-1 yr
Number of subjects: 1355

Group type: COMPARATOR
Intervention: 1/3D
Number of subjects: 1355

Group type: COMPARATOR
Intervention: FD
Number of subjects: 1355

Group type: EXPERIMENTAL
Intervention: 1/3D-3 yr
Number of subjects: 1355
Study: 22024058

Group type: EXPERIMENTAL
Intervention: Da-Cheng-Qi-Tang (DCQT)
Number of subjects: 69
Study: 19190928

Group type: EXPERIMENTAL
Intervention: 600 microg powdery sublingual misoprostol
Number of subjects: 54

Group type: COMPARATOR
Intervention: 600 microg sublingual misoprostol tablet
Number of subjects: 54
Study: 17196475

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg/day for 4 days
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily for 3 days
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combination of aspirin and ranitidine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aspirin with ranitidine
Number of subjects: 10
Study: 15273579

Group type: EXPERIMENTAL
Intervention: Enhanced counseling
Number of subjects: 4328

Group type: EXPERIMENTAL
Intervention: Brief counseling
Number of subjects: 4328

Group type: COMPARATOR
Intervention: Educational messages
Number of subjects: 4328
Study: 11305769

Group type: EXPERIMENTAL
Intervention: Standardized management plus cerebral decompression (decompressive bitemporal craniectomy performed at a median of 19.2 h after injury)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standardized management alone (control group)
Number of subjects: 27
Study: 9387942

Group type: EXPERIMENTAL
Intervention: Budesonide 200 microg b.i.d. for 12 months
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 7636948

Group type: EXPERIMENTAL
Intervention: Milk-fed group
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 5% glucose, water-fed group
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (preprandial baseline)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Celiac artery
Number of subjects: 45
Study: 3233185

Group type: EXPERIMENTAL
Intervention: Topical administration of RA gel
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 41
Study: 2129513

Group type: EXPERIMENTAL
Intervention: Aerobic walking training requiring 90-100% HR of the AT level for 30 min, four to six days per week
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no aerobic training)
Number of subjects: 27
Study: 4564378

Group type: EXPERIMENTAL
Intervention: Tolbutamide
Number of subjects: 0
Study: 30738980

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: CRT-P
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 614

Group type: COMPARATOR
Intervention: Optimal Pharmacologic Therapy (OPT)
Number of subjects: 614
Study: 28481883

Group type: EXPERIMENTAL
Intervention: TV003 vaccine (live attenuated tetravalent dengue vaccine)
Number of subjects: 58
Study: 25858003

Group type: EXPERIMENTAL
Intervention: valsartan 80 mg/daily
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: valsartan 160 mg/daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 100
Study: 24108316

Group type: EXPERIMENTAL
Intervention: Vitamin D₃ 4000 IU/d
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 21521683

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Routine sedative protocol (Midazolam and fentanyl) (group M)
Number of subjects: 72
Study: 19549033

Group type: EXPERIMENTAL
Intervention: Maximum voltage-guided (MVG) technique
Number of subjects: 69

Group type: COMPARATOR
Intervention: Anatomical approach
Number of subjects: 69
Study: 17938318

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (ATY)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 300
Study: 15029143

Group type: EXPERIMENTAL
Intervention: Captopril (37.5‐150 mg, average dose 72+/‐34.2 mg/day)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Eprosartan (300‐600 mg, average dose 471+/‐151 mg/day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 66

Group type: COMPARATOR
Intervention: Eprosartan
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 66
Study: 11775049

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR
Number of subjects: 2021

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2021
Study: 9770742

Group type: EXPERIMENTAL
Intervention: Optimal pedalling rate (OPR) 60 rpm
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Muscular load chosen by the patient (regimen 2)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Free-choice daily load (regimen 3)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Optimal pedalling rate (OPR) 30 and 45 rpm
Number of subjects: 124
Study: 7936300

Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2457043

Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 40

Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 40
Study: 29601270

Group type: EXPERIMENTAL
Intervention: Goal-setting text message reminders
Number of subjects: 50

Group type: COMPARATOR
Intervention: Generic text message reminders
Number of subjects: 50
Study: 27165052

Group type: COMPARATOR
Intervention: List of wishes/statements (LOS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Go Wish card game (GWG)
Number of subjects: 100
Study: 24462657

Group type: EXPERIMENTAL
Intervention: Echocardiography-guided (EG) left ventricular lead placement
Number of subjects: 183

Group type: COMPARATOR
Intervention: Routine strategy for left ventricular lead placement
Number of subjects: 183
Study: 22926853

Group type: EXPERIMENTAL
Intervention: Erythropoietin (33,000 IU intravenously daily for 3 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (as an add-on therapy to methylprednisolone)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Erythropoietin
Number of subjects: 40
Study: 20730705

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg twice daily)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Diane (35) Diario contraceptive pill (35 μg of ethynylestradiol plus 2 mg of cyproterone acetate)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 34
Study: 17393448

Group type: EXPERIMENTAL
Intervention: 5 degrees lateral-wedge insole
Number of subjects: 90

Group type: COMPARATOR
Intervention: Neutral insole
Number of subjects: 90
Study: 16112085

Group type: EXPERIMENTAL
Intervention: Cisplatin and paclitaxel treatment in patients with valine homozygotic genotype
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Cisplatin and paclitaxel treatment in patients with G allele
Number of subjects: 111
Study: 11961333

Group type: EXPERIMENTAL
Intervention: Fluoride chewing gums
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Urea chewing gums
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo chewing gums
Number of subjects: 15

Group type: COMPARATOR
Intervention: No gum
Number of subjects: 15
Study: 10331327

Group type: EXPERIMENTAL
Intervention: Pediapred (Medeva Pharmaceuticals, Rochester, NY)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prelone (Muro Pharmaceuticals, Tewksbury, MA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prednisone oral solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prednisone intensol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prednisone 10‐mg tablet crushed in 10 mL of cherry syrup
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost comparison of each formulation
Number of subjects: 0
Study: 9112163

Group type: EXPERIMENTAL
Intervention: Sublingual administration of 20 microliters of 0.5% timolol solution
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Unilateral ocular administration of 20 microliters of 0.5% timolol solution
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sublingual administration of 20 microliters of saline solution (placebo)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Unilateral ocular administration of 20 microliters of saline solution (placebo)
Number of subjects: 17
Study: 1745711

Group type: EXPERIMENTAL
Intervention: 100 g sugar with alcohol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 35 g sugar with alcohol
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0 g sugar with alcohol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sugar without alcohol
Number of subjects: 0
Study: 6351607

Group type: EXPERIMENTAL
Intervention: Immunosuppressive agents
Number of subjects: 102

Group type: COMPARATOR
Intervention: Oral corticosteroids alone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Activity and chronicity indexes
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Age and chronicity index
Number of subjects: 102
Study: 31500679

Group type: EXPERIMENTAL
Intervention: LSD (100 µg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg) pretreatment with LSD
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 29411727

Group type: EXPERIMENTAL
Intervention: Allograft + T-PRF
Number of subjects: 25

Group type: COMPARATOR
Intervention: Allograft
Number of subjects: 25
Study: 27005405

Group type: EXPERIMENTAL
Intervention: liraglutide 3.0 mg
Number of subjects: 359

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 359
Study: 25263254

Group type: EXPERIMENTAL
Intervention: BTX-A 25U
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: BTX-A 75U
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 23006613

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (100,000 IU monthly)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 20354522

Group type: EXPERIMENTAL
Intervention: Metronomic cyclophosphamide (50 mg b.i.d)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Megestrol acetate (160 mg daily)
Number of subjects: 88
Study: 18033974

Group type: EXPERIMENTAL
Intervention: Various tonsillectomy techniques (9 different techniques)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Standardized protocol for future studies
Number of subjects: 44
Study: 15708051

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (SC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 12486342

Group type: EXPERIMENTAL
Intervention: Single BAK fusion cage inserted posterolaterally with unilateral facetectomy and hemilaminectomy (Group 1)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Two BAK fusion cages inserted posteriorly with bilateral facetectomy and laminectomy (Group 2)
Number of subjects: 25
Study: 10213254

Group type: EXPERIMENTAL
Intervention: Alveolar macrophages (AM) from children with recurrent infections
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal controls (children without recurrent infections)
Number of subjects: 0
Study: 7606951

Group type: EXPERIMENTAL
Intervention: DeVilbiss Pulmo‐Aide compressor with the Marquest Acorn II nebulizer
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Hudson T Up‐draft nebulizer
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Pari LC Jet Plus nebulizer with the Pari Inhalier Boy compressor
Number of subjects: 397
Study: 2193071

Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 30
Study: 42487

Group type: EXPERIMENTAL
Intervention: Timolol (multiple doses)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Timolol (twice-daily schedule)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Timolol (single oral doses)
Number of subjects: 2
Study: 31771436

Group type: EXPERIMENTAL
Intervention: Ketofol (1:3) - low-dose ketamine 0.15 mg/kg followed by propofol 0.45 mg/kg i.v.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control - normal saline and dextrose
Number of subjects: 120
Study: 30623905

Group type: EXPERIMENTAL
Intervention: Prenatal education based on the Roy Adaptation Model
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (due medical care alone)
Number of subjects: 132
Study: 27704286

Group type: EXPERIMENTAL
Intervention: Herniectomy and DIAM spinal stabilization system
Number of subjects: 146

Group type: COMPARATOR
Intervention: Herniectomy alone
Number of subjects: 146
Study: 26215946

Group type: EXPERIMENTAL
Intervention: 4% aqueous lidocaine
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 4% aqueous lidocaine (after open-label use)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 46
Study: 23371895

Group type: EXPERIMENTAL
Intervention: TXA loading dose of 50 mg/kg over 15 min followed by a 5 mg/kg/h maintenance infusion during surgery
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Simulated loading dose of 10 mg/kg over 15 min followed by a 5 mg/kg/h maintenance infusion
Number of subjects: 23
Study: 21080787

Group type: EXPERIMENTAL
Intervention: Coronally positioned flap (CPF) with anorganic bone mineral/peptide‐15 (ABM/P‐15)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Coronally positioned flap (CPF) only
Number of subjects: 15